HMGB1 and juvenile idiopathic arthritis: In conclusion, serum HMGB1 may be associated with clinical disease activity of JIA and specifically increased at the first visit in children with systemic JIA, suggesting its function as a sensitive inflammatory marker and an immunotherapy target.